Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease

Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease
复制标题

大麻素受体 1/miR-30b-5p 轴控制肝脏炎症性疾病中巨噬细胞 NLRP3 表达和炎症小体激活

DOI:
10.1016/j.omtn.2020.04.010
复制
发表时间:
2020-04
期刊:
Molecular Therapy - Nucleic Acids
影响因子:
--
通讯作者:
Li Liying
Li Liying
中科院分区:
其他
文献类型:
--
作者:
Yang Le;Tian Lei;Zhang Zhi;Zhou Xuan;Ji Xiaofang;Liu Fuquan;Dong Chengbin;Hou Lei;Zhao Xinhao;Chang Na;Yang Lin;Li Liying

文献摘要

参考文献

被引文献

相似文献

nod样受体(NLR)家族pyrin domain containing 3 (NLRP3)被认为是多种炎症性疾病的重要启动子或启动子。然而,大麻素受体1 (cannabinoid receptor 1, CB1)与巨噬细胞NLRP3炎症小体的关系及其在肝脏炎症中的分子机制尚不清楚。采用四氯化碳(CCl4)或蛋氨酸-胆碱缺乏和高脂肪(MCDHF)饲料诱导小鼠肝损伤模型。从不同的慢性肝病患者获得人肝组织。CCl4-和mcdhf处理小鼠肝组织和巨噬细胞中CB1表达升高,与NLRP3呈正相关。CB1激动剂ACEA(花生四烯基-2′-氯乙胺)促进巨噬细胞NLRP3表达和NLRP3炎性体活化。在CCl4-和mcdhf处理的小鼠中,CB1拮抗剂AM281阻断可降低NLRP3表达、炎性体激活和肝脏炎症。MicroRNA-30b-5p (miR-30b-5p)通过生物信息学数据库与损伤肝脏中下调的mirna交叉筛选,在小鼠和人肝脏中与NLRP3呈负相关。miR-30b-5p通过直接靶向NLRP3参与巨噬细胞中cb1介导的NLRP3炎性体的激活。重要的是,给药miR-30b-5p agomir靶向NLRP3并减轻损伤肝脏的肝脏炎症。总之,CB1/miR-30b-5p轴调节肝脏炎症期间巨噬细胞中NLRP3的表达和NLPR3炎性体的激活,这为肝脏疾病提供了一个潜在的靶点。
Nod-like receptor (NLR) family pyrin domain containing 3 (NLRP3) has been regarded as an important initiator or promoter in multiple inflammatory diseases. However, the relationship between cannabinoid receptor 1 (CB1) and macrophage NLRP3 inflammasome and the corresponding molecular mechanism in liver inflammation remain unclear. Mouse liver injury models were induced by carbon tetrachloride (CCl4) or methionine-choline-deficient and high fat (MCDHF) diet. Human liver tissues were obtained from patients with different chronic liver diseases. CB1 expression was increased in liver tissue and macrophages of CCl4- and MCDHF-treated mice, positively correlated with NLRP3. CB1 agonist ACEA (Arachiodonyl-2'-Chloroethylamide) promoted NLRP3 expression and NLRP3 inflammasome activation in macrophages. CB1 blockade with its antagonist AM281 reduced NLRP3 expression, inflammasome activation, and liver inflammation in CCl4- and MCDHF-treated mice. MicroRNA-30b-5p (miR-30b-5p), screened by the intersection of bioinformatics databases and downregulated miRNAs in injured liver, negatively correlated with NLRP3 in mouse and human liver. miR-30b-5p was involved in CB1-mediated activation of NLRP3 inflammasome in macrophages by directly targeting NLRP3. Importantly, administration of miR-30b-5p agomir targeted NLRP3 and attenuated liver inflammation in the injured liver. Altogether, CB1/miR-30b-5p axis modulates NLRP3 expression and NLPR3 inflammasome activation in macrophages during liver inflammation, which provides a potential target for liver disease.
DOI: 10.1016/j.jhep.2009.01.028
发表时间: 2009-06-01
影响因子: 25.7
作者:
Li, Changyong;Kong, Yaxian;Li, Liying
通讯作者: Li, Liying
DOI: 10.1136/gutjnl-2016-312108
发表时间: 2016-06
期刊: Gut
影响因子: 24.5
作者:
A. Mallat;S. Lotersztajn
通讯作者: A. Mallat;S. Lotersztajn
DOI: 10.1016/j.omtn.2017.06.005
发表时间: 2017-09-15
期刊: Molecular therapy. Nucleic acids
影响因子: --
作者:
Chakraborty C;Sharma AR;Sharma G;Doss CGP;Lee SS
通讯作者: Lee SS
DOI: 10.1136/gutjnl-2015-310212
发表时间: 2016-10
期刊: Gut
影响因子: 24.5
作者:
Suk KT;Mederacke I;Gwak GY;Cho SW;Adeyemi A;Friedman R;Schwabe RF
通讯作者: Schwabe RF
DOI: 10.1002/hep.26592
发表时间: 2014-03
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Wree, Alexander;Eguchi, Akiko;McGeough, Matthew D.;Pena, Carla A.;Johnson, Casey D.;Canbay, Ali;Hoffman, Hal M.;Feldstein, Ariel E.
通讯作者: Feldstein, Ariel E.